合肥立方制药股份有限公司
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2002-07-16
- Employees
- 691
- Market Cap
- -
- Website
- https://www.lifeon.cn
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
119
NMPA:119
Drug Approvals
Timolol Maleate Eye Drops
- Product Name
- 马来酸噻吗洛尔滴眼液
- Approval Number
- 国药准字H20253876
- Approval Date
- Apr 15, 2025
NMPA
Methylphenidate Hydrochloride Prolonged-Release Tablets
- Product Name
- 盐酸哌甲酯缓释片
- Approval Number
- 国药准字H20253813
- Approval Date
- Apr 8, 2025
NMPA
Paliperidone Extended-Release Tablets
- Product Name
- 帕利哌酮缓释片
- Approval Number
- 国药准字H20253742
- Approval Date
- Mar 25, 2025
NMPA
Paliperidone Extended-Release Tablets
- Product Name
- 帕利哌酮缓释片
- Approval Number
- 国药准字H20253743
- Approval Date
- Mar 25, 2025
NMPA
Proparacaine Hydrochloride Eye Drops
- Product Name
- 盐酸丙美卡因滴眼液
- Approval Number
- 国药准字H20253428
- Approval Date
- Feb 20, 2025
NMPA
Oxycodone Hydrochloride Prolonged-release Tablets
- Product Name
- 盐酸羟考酮缓释片
- Approval Number
- 国药准字H20247237
- Approval Date
- Sep 30, 2024
NMPA
Nifedipine Controlled-release Tablets
- Product Name
- 硝苯地平控释片
- Approval Number
- 国药准字H20213898
- Approval Date
- Jul 23, 2024
NMPA
Metformin Hydrochloride and Glipizide Tablets
- Product Name
- 二甲双胍格列吡嗪片
- Approval Number
- 国药准字H20090086
- Approval Date
- Nov 3, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
Clinical Trials
No trials found
News
No news found